Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sensory Effects of Oral Opioid Treatment in Patients With Chronic Low Back Pain
NCT02824276Phase 1Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jan 2017
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxycodone and morphine in chronic low back pain (CLBP) (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Changes in Pain Sensitivity at 6 months. Started Jan 2017; status: completed.
02
Drugs
oxycodonemorphine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT02824276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02824276.